15-keto-13, 14-dihydroprostaglandin F_2α and prolactin in maternal and cord blood during prostaglandin E₂ or oxytocin therapy for labor induction

Articles in the same Issue

1. Titelei
2. Review article
3. Announcement
4. A randomized study of two cups for vacuum extraction
5. Heterogeneity of congenital primary hypothyroidism: The importance of thyroid scintigraphy
6. 15-keto-13, 14-dihydroprostaglandin F_2α and prolactin in maternal and cord blood during prostaglandin E₂ or oxytocin therapy for labor induction
7. Announcement
8. Low Apgar score as a risk factor for respiratory disturbances in the newborn infant
9. Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy
10. The effect of placenta previa localization upon maternal and fetal-neonatal outcome
11. Announcements
12. Combined electronic fetal heart rate and fetal movement monitor — a preliminary report
13. Neonatal manifestations of maternal phencyclidine exposure
14. Morphometric investigations of terminal villi of diabetic placentas in relation to the White classification of diabetes mellitus
15. Short communications
16. Announcement
17. Guidelines & Checklist